UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The NMR characterization of locked conformations of two stereoisomers of calix[4]tetrahydrofuran

Magnetic resonance in chemistry, 2016-12, Vol.54 (12), p.985-991

2016

Volltextzugriff (PDF)

LifeTime and improving European healthcare through cell-based interceptive medicine

Nature (London), 2020-11, Vol.587 (7834), p.377-386

2020

Volltextzugriff (PDF)

Effect of Early Sustained Prophylactic Hypothermia on Neurologic Outcomes Among Patients With Severe Traumatic Brain Injury: The POLAR Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2018-12, Vol.320 (21), p.2211

2018

Volltextzugriff (PDF)

Cytochrome 2B6 polymorphism and efavirenz‐induced central nervous system symptoms : a substudy of the ANRS ALIZE trial

HIV medicine, 2017-09, Vol.18 (8), p.537-545

2017

Volltextzugriff (PDF)

Use of Efavirenz Is Not Associated with a Higher Risk of Depressive Disorders: A Substudy of the Randomized Clinical Trial ALIZE-ANRS 099

Clinical infectious diseases, 2006-06, Vol.42 (12), p.1790-1799

2006

Volltextzugriff (PDF)

Design, optical characterization, and operation of large transmission gratings for the laser integration line and laser megajoule facilities

Applied Optics, 2005-06, Vol.44 (16), p.3143

2005

Volltextzugriff (PDF)

Phase I study of a candidate vaccine based on recombinant HIV-1 gp160 (MN/LAI) administered by the mucosal route to HIV-seronegative volunteers: The ANRS VAC14 study

Vaccine, 2008-05, Vol.26 (21), p.2657-2666

2008

Volltextzugriff (PDF)

Incidence of and Risk Factors for Adverse Drug Reactions in a Prospective Cohort of HIV-Infected Adults Initiating Protease Inhibitor—Containing Therapy

Clinical infectious diseases, 2004-07, Vol.39 (2), p.248-255

2004

Volltextzugriff (PDF)

Publisher Correction: LifeTime and improving European healthcare through cell-based interceptive medicine

Nature (London), 2021-04, Vol.592 (7852), p.E8-E8

2021

Volltextzugriff (PDF)

Zac1 Regulates the Differentiation and Migration of Neocortical Neurons via Pac1

The Journal of neuroscience, 2015-09, Vol.35 (39), p.13430-13447

2015

Volltextzugriff (PDF)

Simplification Therapy with Once-Daily Emtricitabine, Didanosine, and Efavirenz in HIV-1–Infected Adults with Viral Suppression Receiving a Protease Inhibitor–Based Regimen: A Randomized Trial

The Journal of infectious diseases, 2005-03, Vol.191 (6), p.830-839

2005

Volltextzugriff (PDF)

Laser damage phenomena relevant to the design and operation of an ICF laser driver

Journal of physics. Conference series, 2008-05, Vol.112 (3), p.032013

2008

Volltextzugriff (PDF)

Validation of a risk-assessment scale and a risk-adapted monitoring plan for academic clinical research studies — The Pre-Optimon study

Contemporary clinical trials, 2011-01, Vol.32 (1), p.16-24

2011

Volltextzugriff (PDF)

Once-Daily Combination Therapy with Emtricitabine, Didanosine, and Efavirenz in Human Immunodeficiency Virus—Infected Patients

The Journal of infectious diseases, 2000-08, Vol.182 (2), p.599-602

2000

Volltextzugriff (PDF)

Biosynthesis of the major scent components 3,5-dimethoxytoluene and 1,3,5-trimethoxybenzene by novel rose O-methyltransferases

FEBS letters, 2002-07, Vol.523 (1), p.113-118

2002

Volltextzugriff (PDF)

Four year follow-up of simplification therapy with once-daily emtricitabine, didanosine and efavirenz in HIV-infected patients (ALIZE ANRS 099 trial)

Journal of antimicrobial chemotherapy, 2011, Vol.66 (1), p.184-191

2011

Volltextzugriff (PDF)

Characterization of the Methylation-sensitive Promoter of the Imprinted ZAC Gene Supports Its Role in Transient Neonatal Diabetes Mellitus

The Journal of biological chemistry, 2001-06, Vol.276 (22), p.18653-18656

2001

Volltextzugriff (PDF)

The expression of the antiproliferative gene ZAC is lost or highly reduced in nonfunctioning pituitary adenomas

Cancer research (Chicago, Ill.), 2000-12, Vol.60 (24), p.6794-6799

2000

Volltextzugriff (PDF)

Role of Long-Term Nucleoside-Analogue Therapy in Lipodystrophy and Metabolic Disorders in Human Immunodeficiency Virus—Infected Patients

Clinical infectious diseases, 2002-03, Vol.34 (5), p.649-657

2002

Volltextzugriff (PDF)

Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy

AIDS (London), 2001-12, Vol.15 (18), p.2441-2444

2001

Volltextzugriff (PDF)

Incidence and risk factors of bacterial pneumonia requiring hospitalization in HIV‐infected patients started on a protease inhibitor‐containing regimen

HIV medicine, 2006-05, Vol.7 (4), p.261-267

2006

Volltextzugriff (PDF)

Factors Related to Lipodystrophy and Metabolic Alterations in Patients with Human Immunodeficiency Virus Infection Receiving Highly Active Antiretroviral Therapy

Clinical infectious diseases, 2002-05, Vol.34 (10), p.1396-1405

2002

Volltextzugriff (PDF)

MACVIA-LR, Reference site of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) in Languedoc Roussillon

European geriatric medicine, 2014-12, Vol.5 (6), p.406-415

2014

Volltextzugriff (PDF)

Modeling changes in CD4-positive T-lymphocyte counts after the start of highly active antiretroviral therapy and the relation with risk of opportunistic infections: The aquitaine cohort, 1996-1997

American journal of epidemiology, 2001-02, Vol.153 (4), p.386-393

2001

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(53)

Sprache

Englisch
(47)
Französisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(35)
Humans
(34)
Infectious Diseases
(26)
Female
(24)
Male
(23)
Adult
(22)
Hiv Infections - Drug Therapy
(22)
Biological And Medical Sciences
(21)
Medical Sciences
(20)
Hiv
(14)
Immunology
(14)
Pharmacology. Drug Treatments
(13)
Microbiology
(12)
Rna, Viral - Blood
(12)
Cd4 Lymphocyte Count
(11)
Middle Aged
(11)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(10)
Antiviral Agents
(10)
Human Immunodeficiency Virus
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The NMR characterization of locked conformations of two stereoisomers of calix[4]tetrahydrofuran

Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE)

LifeTime and improving European healthcare through cell-based interceptive medicine

Effect of Early Sustained Prophylactic Hypothermia on Neurologic Outcomes Among Patients With Severe Traumatic Brain Injury: The POLAR Randomized Clinical Trial

Cytochrome 2B6 polymorphism and efavirenz‐induced central nervous system symptoms : a substudy of the ANRS ALIZE trial

Use of Efavirenz Is Not Associated with a Higher Risk of Depressive Disorders: A Substudy of the Randomized Clinical Trial ALIZE-ANRS 099

Design, optical characterization, and operation of large transmission gratings for the laser integration line and laser megajoule facilities

Phase I study of a candidate vaccine based on recombinant HIV-1 gp160 (MN/LAI) administered by the mucosal route to HIV-seronegative volunteers: The ANRS VAC14 study

Incidence of and Risk Factors for Adverse Drug Reactions in a Prospective Cohort of HIV-Infected Adults Initiating Protease Inhibitor—Containing Therapy

Publisher Correction: LifeTime and improving European healthcare through cell-based interceptive medicine

Zac1 Regulates the Differentiation and Migration of Neocortical Neurons via Pac1

Simplification Therapy with Once-Daily Emtricitabine, Didanosine, and Efavirenz in HIV-1–Infected Adults with Viral Suppression Receiving a Protease Inhibitor–Based Regimen: A Randomized Trial

Laser damage phenomena relevant to the design and operation of an ICF laser driver

Validation of a risk-assessment scale and a risk-adapted monitoring plan for academic clinical research studies — The Pre-Optimon study

Once-Daily Combination Therapy with Emtricitabine, Didanosine, and Efavirenz in Human Immunodeficiency Virus—Infected Patients

Biosynthesis of the major scent components 3,5-dimethoxytoluene and 1,3,5-trimethoxybenzene by novel rose O-methyltransferases

Four year follow-up of simplification therapy with once-daily emtricitabine, didanosine and efavirenz in HIV-infected patients (ALIZE ANRS 099 trial)

Characterization of the Methylation-sensitive Promoter of the Imprinted ZAC Gene Supports Its Role in Transient Neonatal Diabetes Mellitus

The expression of the antiproliferative gene ZAC is lost or highly reduced in nonfunctioning pituitary adenomas

Role of Long-Term Nucleoside-Analogue Therapy in Lipodystrophy and Metabolic Disorders in Human Immunodeficiency Virus—Infected Patients

Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy

Incidence and risk factors of bacterial pneumonia requiring hospitalization in HIV‐infected patients started on a protease inhibitor‐containing regimen

Factors Related to Lipodystrophy and Metabolic Alterations in Patients with Human Immunodeficiency Virus Infection Receiving Highly Active Antiretroviral Therapy

MACVIA-LR, Reference site of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) in Languedoc Roussillon

Modeling changes in CD4-positive T-lymphocyte counts after the start of highly active antiretroviral therapy and the relation with risk of opportunistic infections: The aquitaine cohort, 1996-1997

Suchergebnisse filtern